Cite
Suzuki J, Sasabuchi Y, Hatakeyama S, et al. Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort study. Pneumonia (Nathan). 2022;14(1):1doi: 10.1186/s41479-021-00093-8.
Suzuki, J., Sasabuchi, Y., Hatakeyama, S., Matsui, H., Sasahara, T., Morisawa, Y., Yamada, T., Fushimi, K., & Yasunaga, H. (2022). Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort study. Pneumonia (Nathan Qld.), 14(1), 1. https://doi.org/10.1186/s41479-021-00093-8
Suzuki, Jun, et al. "Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort study." Pneumonia (Nathan Qld.) vol. 14,1 (2022): 1. doi: https://doi.org/10.1186/s41479-021-00093-8
Suzuki J, Sasabuchi Y, Hatakeyama S, Matsui H, Sasahara T, Morisawa Y, Yamada T, Fushimi K, Yasunaga H. Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort study. Pneumonia (Nathan). 2022 Jan 10;14(1):1. doi: 10.1186/s41479-021-00093-8. PMID: 35012674; PMCID: PMC8744237.
Copy
Download .nbib